Recently recommended that there is a Advisory Committee for the Food and Drug Administration (FDA) not to approve what has been nicknamed “Small pink pill” designed to address the lack of sexual desire for females (instead of Viagra, “small blue pill” for men). Food and Drug Administration for approval in any case, but rarely at any time decide differently from the Advisory Group. According to clinical trials sponsored by pharmaceutical company, Boehringer Ingelheim pre-menopausal women Flibanserin increased slightly to address sexual activity, compared with women who drank a placebo, however, the Panel decided that the amount of the increase did not exceed the negative effects.
Tuesday, July 6, 2010
Tantra Sexuality
Recently recommended that there is a Advisory Committee for the Food and Drug Administration (FDA) not to approve what has been nicknamed “Small pink pill” designed to address the lack of sexual desire for females (instead of Viagra, “small blue pill” for men). Food and Drug Administration for approval in any case, but rarely at any time decide differently from the Advisory Group. According to clinical trials sponsored by pharmaceutical company, Boehringer Ingelheim pre-menopausal women Flibanserin increased slightly to address sexual activity, compared with women who drank a placebo, however, the Panel decided that the amount of the increase did not exceed the negative effects.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment